Palliative Care Communication With Alaska Native and American Indian People
NCT ID: NCT03256110
Last Updated: 2021-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2019-01-28
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Experiences to Inform Improved Communication for Minorities With Life Limiting Illness
NCT03391115
Culturally-Adapting a Communication Intervention to Improve Palliative Care Literacy on Two Native American Reservations
NCT03569150
Palliative Care Messaging for American Indians
NCT06359392
Motivational Interviewing in Palliative Care
NCT03332615
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
NCT03767517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Patients and providers in this arm receive the culturally-tailored Improving Communication about Serious Illness (ICSI) Intervention. The ICSI involves providing the provider and the patient with an individualized, one-page summary of patient-specific preferences for advance care planning communication that prompts the patient and the provider to have a conversation about advance care planning at the next clinical visit.
Improving Communication about Serious Illness-AI/AN
A one-page summary of patient-specific preferences, barriers and facilitators for engaging in patient-provider communication about advance care planning, provided to patient and provider prior to a clinical encounter with prompts for initiating and/or improving the quality of communication about advance care planning.
Control
Patients and providers in this arm receive usual care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Improving Communication about Serious Illness-AI/AN
A one-page summary of patient-specific preferences, barriers and facilitators for engaging in patient-provider communication about advance care planning, provided to patient and provider prior to a clinical encounter with prompts for initiating and/or improving the quality of communication about advance care planning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older (patients and providers)
* Employed at least 2 years as a primary care provider at one of the two study sites (providers)
* Have a primary care provider of record at one of the two study sites (patients)
* Have had at least 2 visits with primary care provider in previous 12 months (patients)
* Having at least one serious, life-limiting condition, including metastatic cancer, primary lung cancer, chronic obstructive pulmonary disorder, heart disease, liver disease or cirrhosis, renal failure, or being oxygen dependent. (patients)
Exclusion Criteria
* Not Alaska Native or American Indian (patients)
* Not having a primary care provider at one of the study sites (patients)
* Not being employed for at least two years as a primary care provider at one of the study sites (providers)
* Not having had at least 2 visits with a primary care providers at one of the study sites in the previous 12 months (patients)
* Not having a serious, life-limiting condition, such as metastatic cancer, primary lung cancer, chronic obstructive pulmonary disorder, heart disease, liver disease or cirrhosis, renal failure, or being oxygen dependent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
University of New Mexico
OTHER
Washington State University
OTHER
University of Washington
OTHER
Southcentral Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Shaw
Senior Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Shaw, PhD
Role: PRINCIPAL_INVESTIGATOR
Southcentral Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southcentral Foundation
Anchorage, Alaska, United States
First Nations Community HealthSource
Albuquerque, New Mexico, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.